Non-Hodgkin Lymphoma

May 30, 2017

FDA to Review Kite’s Application for CAR T-Cell Therapy to Treat Aggressive Non-Hodgkin’s Lymphoma

News

The U.S. Food and Drug Administration (FDA) has accepted for review the biologics license application (BLA) seeking the approval of axicabtagene ciloleucel (KTE-C19) for the treatment of refractory aggressive non-Hodgkin’s ... Read more

April 5, 2017

Janssen Hits Snag with Darzalex Phase 2 Trial for Non-Hodgkin’s Lymphoma

News

Stage 1 of the Phase 2 trial of Darzalex (daratumumab) in relapsed or refractory non-Hodgkin’s lymphomas has failed to reach the predefined thresholds of overall response rates in the follicular lymphoma (FL) ... Read more

March 24, 2017March 24, 2017

CAR T-cell Therapy Induces Durable Complete Responses in Some Non-Hodgkin Lymphoma Patients

News

Kite Pharma’s anti-CD19 CAR T-cell therapy is a promising approach to treat patients with relapsed or refractory non-Hodgkin lymphoma, according to data from a Phase 1 clinical trial. James N. ... Read more

March 6, 2017

British Military Service Not Linked to Higher Risk of Lymphoma and Leukemia, Study Finds

News

British veterans living in Scotland are at no greater risk of lymphoma or leukemia than the general population, a finding that offers reassurance that military service is not associated with ... Read more

March 3, 2017March 3, 2017

RNA Molecule Could Be Used to Develop Therapies for Aggressive Lymphomas, Study Reports

News

The small non-coding RNA molecule called microRNA-28 has anti-tumor effects against Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) cells, according to a study. The molecule, which prevents immune-system components known ... Read more

February 17, 2017

Oil, Gas Activity Linked to Leukemia, But Not Lymphoma, in Kids Living Near Wells

News

Children with acute lymphoblastic leukemia (ALL) are four times more likely to live near areas of active oil and gas development than those with non-hematological cancers, according to a recent study ... Read more

February 8, 2017

Strata to Help Epizyme Find Patients for Non-Hodgkin Lymphoma Trial of Tazemetostat

News

Strata Oncology will help Epizyme accelerate patient enrollment in the Phase 2 clinical trial assessing Epizyme’s EZH2 inhibitor tazemetostat in patients with relapsed or refractory non-Hodgkin lymphoma. Strata is conducting ... Read more

February 7, 2017

21st Century Blood Transfusions Associated with Higher Risk of Non-Hodgkin’s Lymphoma, Liver Cancer

News

Women who underwent a blood transfusion more than five years ago may be at greater risk of developing liver cancer and non-Hodgkin’s lymphoma, according to a large prospective study. The study, ... Read more

January 24, 2017

Men’s Exposure to Work-Related Stress Linked to Non-Hodgkin Lymphoma, 4 Other Cancers

News

For men, exposure to perceived stress at work throughout their entire career is associated with greater likelihood of non-Hodgkin lymphoma, as well as lung, colon, rectal, and stomach cancers, according ... Read more

January 13, 2017

$42M European Initiative Aims to Improve Care for Blood Disorder Patients

News

A new European initiative aims to use big data to improve outcomes for patients with blood diseases. Consisting of 51 partners from 11 European countries, the HARMONY project is focused ... Read more